Moolec Science (MLECW) Liabilities and Shareholders Equity (2022 - 2026)

Moolec Science has reported Liabilities and Shareholders Equity for 5 years, with the latest figure at $104.2 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity changed N/A year-over-year to $104.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $443.5 million (changed N/A YoY) and the FY2025 annual result came in at $204.6 million, down 78.46% from the prior year.
• Liabilities and Shareholders Equity climbed to $104.2 million in Q1 2026 per MLECW's latest filing, from $103.4 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $949.8 million in Q2 2024 and troughed at $5.7 million in Q2 2022.
• A 5-year average of $119.7 million and a median of $26.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity soared 3849.21% in 2024, then slumped 78.46% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $23.2 million in 2022, then retreated by 8.01% to $21.3 million in 2023, then surged by 47.19% to $31.4 million in 2024, then soared by 229.46% to $103.4 million in 2025, then advanced by 0.78% to $104.2 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $104.2 million, $103.4 million, and $204.6 million for Q1 2026, Q4 2025, and Q2 2025 respectively.